Ledger.Open graph →
SEC Form D · filed December 16, 2013

New Health Sciences, Inc

Offering
$17.6M
Sold
$12.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Bethesda, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

John Rubino · Bluffton, SCDirectorBrett Topche · Philadelphia, PAExec · DirectorDavid Shatz · Bluffton, SCExecMichael Aronson · Philadelphia, PADirectorDaniel T. Rewalt · Grand Cayman, Cayman IslandsDirectorTeng Wui Leong · Singapore, U0Exec · DirectorAaron C. Rothstein · Lihue, HIDirectorDr. Mark T. Rothstein · Athens, OHDirectorRobert A. Shen · Milpitas, CAExecSteven R. Yost · Lihue, HIDirectorSteve Eckert · Bethesda, MDDirectorDavid Testa · Bethesda, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗